EU Needs More Teamwork On Drug Pricing & Access
HTA, Generics and Biosimilars Are Also In The Frame
Executive Summary
EU member states are being urged by the European Commission to cooperate more closely on pricing and reimbursement, managed access deals and policies to promote generics and biosimilars.